EPHX2 and breast cancer: Rather surprisingly, given the previous reports that linked increased CYP enzyme and decreased sEH expression with more aggressive breast cancer tumors in humans [12], as well as a significant increase in tumor metastasis in sEH-deficient mice [13,22], we detected no effect of sEH deletion on the spreading of the primary tumor to the lymph nodes or the lung.